Bolt Biotherapeutics Inc. (BOLT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.31
0.35 (7.06%)
At close: Oct 03, 2025, 3:59 PM
5.31
0.00%
After-hours: Oct 03, 2025, 07:53 PM EDT

Bolt Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-8.56M -11.04M -15.94M -15.18M -21.2M -10.81M -17.9M -16.26M -18.06M -16.98M -20M -21.76M -22.66M -23.68M -27.16M -23.39M -23.59M -24.45M
Depreciation & Amortization
347K 399K 426K 440K 457K 458K 497K 462K 458K 467K 462K 439K 408K 357K 361K 304K 256K 272K
Stock-Based Compensation
625K 709K 1.18M 1.1M 2.83M 2.3M 2.07M 2.33M 2.35M 2.48M 2.12M 2.14M 2.39M 2.92M 2.14M 2.23M 2.02M 2.11M
Other Working Capital
-2.46M -3.55M -1.2M -578K 1.77M -8.44M 1.54M -2.69M 518K -2.62M -9.02M -1.21M 1.27M -3.16M -1.29M 555K 15.94M -1.28M
Other Non-Cash Items
454K 118K 1.09M 250K -3K 2.96M 2.6M 744K 731K -133K 234K 682K 894K 1.64M 544K 761K 644K 6.61M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.06M -1.33M -1.11M n/a n/a n/a n/a n/a 929K 822K 740K 271K
Change in Working Capital
-2.46M -3.55M -1.2M -578K 1.77M -8.44M 1.54M -2.69M 518K -9.23M -774K 5.08M -1.82M -5.55M 5.39M 555K 15.94M -1.37M
Operating Cash Flow
-9.6M -13.37M -14.43M -13.97M -16.14M -16.75M -14.27M -16.75M -15.11M -23.4M -17.95M -13.45M -20.79M -24.31M -17.79M -18.73M -3.99M -16.56M
Capital Expenditures
n/a n/a n/a -41K n/a n/a -6K -165K -32K -3K -184K -735K -429K -605K -562K -1.01M -703K -58K
Cash Acquisitions
n/a 963K n/a 148K n/a n/a 55.43M -12.82M -13.61M -28.99M -16.62M n/a 439K n/a n/a n/a n/a n/a
Purchase of Investments
-14.46M -992K -13.25M -20.32M -32.23M -23.06M -32.16M -36.3M -53.64M -42.88M -25.36M -47.91M -31.35M -76.08M -29.69M -35.92M -49.7M -198.07M
Sales Maturities Of Investments
25.26M 14.58M 25.48M 37.35M 50.23M 33.26M 47.98M 49.13M 67.25M 71.88M 41.98M 50.1M 30.91M 117.53M 51.28M 20.82M 3.8M 7.61M
Other Investing Acitivies
n/a n/a n/a n/a n/a 10.2M n/a 12.82M 13.61M 28.99M 16.62M 2.19M -439K 41.45M 21.59M -15.1M -45.9M -190.46M
Investing Cash Flow
10.79M 14.55M 12.23M 17.14M 18M 10.2M 15.81M 12.66M 13.58M 28.99M 16.43M 1.45M -868K 40.84M 21.03M -16.11M -46.6M -190.52M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a -79K 79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
14K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
14K n/a 29K n/a 79K n/a 106K n/a 147K n/a 144K n/a 252K 107K 495K 185K 13.41M 297.02M
Net Cash Flow
1.21M 1.19M -2.17M 3.17M 1.94M -6.55M 1.65M -4.09M -1.39M 5.59M -1.37M -12M -21.4M 16.64M 3.73M -34.65M -37.18M 89.94M
Free Cash Flow
-9.6M -13.37M -14.43M -14.01M -16.14M -16.75M -14.27M -16.91M -15.14M -23.4M -18.14M -14.19M -21.22M -24.92M -18.36M -19.74M -4.69M -16.62M